In-Depth Proteomic Analyses of Direct Expressed Prostatic Secretions

被引:63
作者
Drake, Richard R. [1 ,2 ]
Elschenbroich, Sarah [3 ]
Lopez-Perez, Orlay [3 ]
Kim, Yunee [4 ]
Ignatchenko, Vladimir [3 ]
Ignatchenko, Alex [3 ]
Nyalwidhe, Julius O. [1 ,2 ]
Basu, Gaurav [1 ]
Wilkins, Christopher E. [1 ,2 ]
Gjurich, Breanne [1 ,2 ]
Lance, Raymond S. [1 ,2 ]
Semmes, O. John [1 ,2 ]
Medin, Jeffrey A. [3 ,4 ,5 ,6 ]
Kislinger, Thomas [3 ,5 ,6 ]
机构
[1] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23517 USA
[2] Eastern Virginia Med Sch, Canc Biol & Infect Dis Res Ctr, Norfolk, VA 23517 USA
[3] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada
[4] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada
[6] Campbell Family Canc Res Inst, Toronto, ON, Canada
基金
美国国家卫生研究院;
关键词
prostate cancer; expressed prostatic secretions; proteomics; biomarker; proximal fluid; PROTEIN IDENTIFICATION TECHNOLOGY; TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; LARGE-SCALE; CANCER; BIOMARKERS; DIAGNOSIS; ATLAS; PATHOLOGY; MARKERS;
D O I
10.1021/pr1001498
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
It is expected that clinically obtainable fluids that are proximal to organs contain a repertoire of secreted proteins and shed cells reflective of the physiological state of that tissue and thus represent potential sources for biomarker discovery, investigation of tissue-specific biology, and assay development. The prostate gland secretes many proteins into a prostatic fluid that combines with seminal vesicle fluids to promote sperm activation and function. Proximal fluids of the prostate that can be collected clinically are seminal plasma and expressed prostatic secretion (EPS) fluids. In the current study, MudPIT-based proteomics was applied to EPS obtained from nine men with prostate cancer and resulted in the confident identification of 916 unique proteins. Systematic bioinformatics analyses using publicly available microarray data of 21 human tissues (Human Gene Atlas), the Human Protein Atlas database, and other published proteomics data of shed/secreted proteins were performed to systematically analyze this comprehensive proteome. Therefore, we believe this data will be a valuable resource for the research community to study prostate biology and potentially assist in the identification of novel prostate cancer biomarkers. To further streamline this process, the entire data set was deposited to the Tranche repository for use by other researchers.
引用
收藏
页码:2109 / 2116
页数:8
相关论文
共 27 条
[1]   The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins [J].
Adachi, Jun ;
Kumar, Chanchal ;
Zhang, Yanling ;
Olsen, Jesper V. ;
Mann, Matthias .
GENOME BIOLOGY, 2006, 7 (09)
[2]   Prostate-specificy-antigen testing for early diagnosis of prostate cancer. [J].
Barry, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1373-1377
[3]   2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer [J].
Byrne, Jennifer C. ;
Downes, Michelle R. ;
O'Donoghue, Niaobh ;
O'Keane, Conor ;
O'Neill, Amanda ;
Fan, Yue ;
Fitzpatrick, John M. ;
Dunn, Michael J. ;
Watson, R. William G. .
JOURNAL OF PROTEOME RESEARCH, 2009, 8 (02) :942-957
[4]   Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology [J].
Cox, Brian ;
Kotlyar, Max ;
Evangelou, Andreas I. ;
Ignatchenko, Vladimir ;
Ignatchenko, Alex ;
Whiteley, Kathie ;
Jurisica, Igor ;
Adamson, S. Lee ;
Rossant, Janet ;
Kislinger, Thomas .
MOLECULAR SYSTEMS BIOLOGY, 2009, 5
[5]   PCA3: A molecular urine assay for predicting prostate biopsy outcome [J].
Deras, Ina L. ;
Aubin, Sheila M. J. ;
Blase, Amy ;
Day, John R. ;
Koo, Seongjoon ;
Partin, Alan W. ;
Ellis, William J. ;
Marks, Leonard S. ;
Fradet, Yves ;
Rittenhouse, Harry ;
Groskopf, Jack .
JOURNAL OF UROLOGY, 2008, 179 (04) :1587-1592
[6]   Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].
Draisma, G ;
Boer, R ;
Otto, SJ ;
van der Cruijsen, IW ;
Damhuis, RAM ;
Schröder, FH ;
de Koning, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878
[7]   Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease [J].
Drake, Richard R. ;
White, Krista Y. ;
Fuller, Thomas W. ;
Igwe, Elena ;
Clements, Mary Ann ;
Nyalwidhe, Julius O. ;
Given, Robert W. ;
Lance, Raymond S. ;
Semmes, O. John .
JOURNAL OF PROTEOMICS, 2009, 72 (06) :907-917
[8]   Peptide Separations by On-Line MudPIT Compared to Isoelectric Focusing in an Off-Gel Format: Application to a Membrane-Enriched Fraction from C2C12 Mouse Skeletal Muscle Cells [J].
Elschenbroich, Sarah ;
Ignatchenko, Vladimir ;
Sharma, Parveen ;
Schmitt-Ulms, Gerold ;
Gramolini, Anthony O. ;
Kislinger, Thomas .
JOURNAL OF PROTEOME RESEARCH, 2009, 8 (10) :4860-4869
[9]   Rethinking Screening for Breast Cancer and Prostate Cancer [J].
Esserman, Laura ;
Shieh, Yiwey ;
Thompson, Ian .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (15) :1685-1692
[10]   Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests [J].
Fortin, Tanguy ;
Salvador, Arnaud ;
Charrier, Jean Philippe ;
Lenz, Cristof ;
Lacoux, Xavier ;
Morla, Aymeric ;
Choquet-Kastylevsky, Genevieve ;
Lemoine, Jerome .
MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (05) :1006-1015